SiehYean Kiew

Dr. SiehYean Kiew


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SKSiehYean Kiew
SiehYean Kiew
IYIan Yew San Yeo
Ian Yew San Yeo
KGKarl Golnik
Karl Golnik
MMMaría-Aurora Muriel-Herrero
María-Aurora Muriel-Herrero
VFVanesa Fuertes-Barahona
Vanesa Fuertes-Barahona
Andrzej GrzybowskiAndrzej Grzybowski
Andrzej Grzybowski
(1) Background: Intravitreal injections (IVIs) are the most commonly performed intraocular procedure worldwide. Ensuring correct learning is essential to avoid complications. Our purpose was to develop an internationally valid tool to assess skill in performing IVIs. (2) Methods: A panel of six content experts designed a rubric for assessing the IVI procedure by using a modified Dreyfus scale of skill acquisition, dividing it into steps and providing objective behavioral descriptors for each level of skill in each category, following the International Council of Ophthalmology (ICO) guidance. The rubric draft was then critically reviewed by 12 international content experts, and their constructive comments were considered for the final rubric. (3) Results: The Ophthalmology Surgical Competency Assessment Rubric for IVI (ICO-OSCAR:IVI) is the proposed tool for assessing healthcare professionals training to perform IVI. (4) Conclusions: The ICO-OSCAR:IVI is the result of the consensus of an international expert panel. The methodology used for its development provides this rubric with face and content validity. It can be used globally to assess healthcare professionals training to perform IVI, as well as the impact of different teaching methods on performance. Further studies are required to establish intra- and inter-rater reliability, as well as the predictive validity of this tool.

14 May 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
GYGuan Hui Yap
Guan Hui Yap
BKBarry Moses Quan Ren Koh
Barry Moses Quan Ren Koh
MCMiao Li Chee
Miao Li Chee
RBRiswana Banu
Riswana Banu
SKSiehYean Kiew
SiehYean Kiew
CSCharumathi Sabanayagam
Charumathi Sabanayagam
Background/Objectives: Cystatin C-based and combined creatinine–cystatin C estimated glomerular filtration rate (eGFR) equations improve early chronic kidney disease (CKD) detection and prediction of adverse outcomes compared to creatinine alone. However, their role in predicting microvascular complications such as diabetic retinopathy (DR) is less clear. We examined the association between diabetic kidney disease (DKD), defined using creatinine-, cystatin C-, and combined eGFR measures, as well as albuminuria, and the risk of incident DR among Asian adults in Singapore. Methods: We analysed 1135 Chinese and Indian adults with diabetes aged ≥40 years from a population-based cohort study with baseline (2007–2011) and 6-year follow-up (2013–2017) data. DR was graded from retinal photographs, and incident DR was defined as new-onset at follow-up. DKD was defined as eGFR < 60 mL/min/1.73 m2 using eGFRcr, eGFRcys, combined eGFRcr-cys, and albuminuria (UACR ≥ 30 mg/g), assessed individually and jointly. Modified Poisson regression models adjusted for age, sex, ethnicity, diabetes duration, HbA1c, and systolic blood pressure were used to estimate relative risks (RRs). Results: Overall, incident DR occurred in 13.0% of participants. Among those with DKD, incidence was 18.2% (eGFRcr), 16.7% (eGFRcys), 23.7% (eGFRcr-cys), and 18.3% (albuminuria). eGFRcr-DKD (RR = 2.18, 95% CI 1.33–3.58), eGFRcys-DKD (2.38 [1.51–3.78]), and eGFRcr-cys-DKD (3.15 [1.94–5.12]) were independently associated with incident DR, whereas albuminuria alone was not. Risk increased with increasing number of markers,2.00 (1.02–3.92) by dual and 4.91 (2.50–9.65) by triple markers. Conclusions: DKD defined using multiple kidney markers, particularly combined creatinine–cystatin C, was strongly associated with incident DR. These findings support the use of multiple kidney function markers to improve risk stratification for developing DR.